Projected costs, risks, and benefits of expanded newborn screening for MCADD.

Pediatrics
Lisa A ProsserSusan L Waisbren

Abstract

To evaluate the cost-effectiveness of newborn screening for medium-chain acyl-coenzyme A dehydrogenase deficiency (MCADD) incorporating quality-of-life effects for false-positive newborn screens and recommended dietary treatment. A computer simulation model was developed to predict costs and health outcomes for expanded newborn screening for MCADD compared with clinical identification. The modeled target population was a hypothetical cohort of 100 000 newborns in the United States. Probabilities, costs, and quality-of-life weights were derived from a long-term follow-up study of newborn screening compared with clinical identification, primary data collection, published data, and expert opinion. We used a lifetime time horizon and the societal perspective. The main outcome measure was the incremental cost-effectiveness ratio in dollars per quality-adjusted life-year (QALY) gained. Secondary outcomes included averted deaths and hospitalizations. Using base-case assumptions, the cost-effectiveness of newborn screening for MCADD was $21 273 per QALY gained. The cost-effectiveness ratio increased to $21 278/QALY when the loss in quality of life associated with false-positive test results was incorporated and to $27 423/QALY when the...Continue Reading

Citations

Sep 29, 2011·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·J Lawrence MerrittSi Houn Hahn
Apr 7, 2012·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Lisa A ProsserJames M Perrin
Oct 19, 2013·Orphanet Journal of Rare Diseases·Johannes PfeilPeter Burgard
Jan 31, 2014·Nihon eiseigaku zasshi. Japanese journal of hygiene·Tomiko Kuhara
Nov 2, 2013·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Mindy MorrisJose E Abdenur
Jul 14, 2012·PharmacoEconomics·Lisa A Prosser
Jun 16, 2010·Expert Review of Pharmacoeconomics & Outcomes Research·Scott D GrosseDavid Feeny
Mar 20, 2014·Journal of Obstetric, Gynecologic, and Neonatal Nursing : JOGNN·Audrey Tluczek, Jane M De Luca
May 23, 2015·Applied Health Economics and Health Policy·Stuart J WrightFiona Ulph
Dec 8, 2010·Proteomics. Clinical Applications·William J Savage, Allen D Everett
Dec 4, 2013·Critical Reviews in Clinical Laboratory Sciences·Chloe Miu MakChing-Wan Lam
Aug 8, 2012·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Simrandeep K TiwanaHaesuk Park
Sep 18, 2013·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Ching-Fen HsuWei-Chu Chie
Jan 24, 2019·Journal of Patient-reported Outcomes·Norma-Jean SimonLisa A Prosser
Oct 3, 2017·Health Technology Assessment : HTA·Fiona UlphTina Lavender
Mar 25, 2019·Orphanet Journal of Rare Diseases·Maria D KaraceperUNKNOWN Canadian Inherited Metabolic Diseases Research Network (CIMDRN)
Oct 26, 2021·Medical Decision Making : an International Journal of the Society for Medical Decision Making·Christopher J CadhamDavid T Levy

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.